DI SARNO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.814
AS - Asia 1.397
EU - Europa 979
SA - Sud America 189
AF - Africa 33
OC - Oceania 1
Totale 4.413
Nazione #
US - Stati Uniti d'America 1.755
SG - Singapore 660
RU - Federazione Russa 526
CN - Cina 279
VN - Vietnam 233
BR - Brasile 141
HK - Hong Kong 111
DE - Germania 74
IT - Italia 70
NL - Olanda 67
FI - Finlandia 50
FR - Francia 37
IE - Irlanda 36
GB - Regno Unito 33
SE - Svezia 33
CA - Canada 32
IN - India 23
MX - Messico 21
AR - Argentina 18
UA - Ucraina 17
JP - Giappone 14
ZA - Sudafrica 11
BD - Bangladesh 10
IQ - Iraq 10
EC - Ecuador 9
PL - Polonia 9
TR - Turchia 9
PK - Pakistan 8
CI - Costa d'Avorio 7
CO - Colombia 7
TH - Thailandia 7
ES - Italia 6
ID - Indonesia 6
UZ - Uzbekistan 5
BO - Bolivia 4
CL - Cile 4
CZ - Repubblica Ceca 4
KR - Corea 4
MA - Marocco 4
AT - Austria 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LV - Lettonia 2
NO - Norvegia 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MW - Malawi 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 4.413
Città #
Singapore 329
San Jose 235
Chandler 179
Ashburn 110
Hong Kong 110
Moscow 101
Beijing 95
Ho Chi Minh City 78
Amsterdam 63
Millbury 56
The Dalles 50
Hanoi 43
Santa Clara 43
Jacksonville 42
Los Angeles 42
Nanjing 42
Princeton 35
Lauterbourg 30
New York 28
Wilmington 24
Munich 20
São Paulo 19
Dallas 18
Buffalo 16
Da Nang 14
Mexico City 14
Atlanta 13
Naples 13
Council Bluffs 12
Nanchang 12
Redondo Beach 12
Tokyo 12
Ann Arbor 11
Norwalk 11
Orem 11
Boston 10
Montreal 10
Brooklyn 9
Chicago 9
Helsinki 9
Warsaw 9
Chennai 8
Denver 8
Haiphong 8
Milan 8
Ottawa 8
Phoenix 8
Turku 8
Houston 7
Shenyang 7
London 6
Rio de Janeiro 6
San Francisco 6
Seattle 6
Bangkok 5
Belo Horizonte 5
Kunming 5
Manchester 5
Tianjin 5
Brasília 4
Changsha 4
Erbil 4
Falkenstein 4
Frankfurt am Main 4
Guangzhou 4
Jiaxing 4
Johannesburg 4
Lahore 4
Ningbo 4
Pune 4
Quito 4
Tashkent 4
Toronto 4
Camaçari 3
Des Moines 3
Düsseldorf 3
Hebei 3
Hải Dương 3
Jinan 3
Kuala Lumpur 3
Las Vegas 3
Mumbai 3
Querétaro 3
Quận Một 3
Recife 3
San Sebastiano al Vesuvio 3
Secaucus 3
Tel Aviv 3
Torino 3
Araruama 2
Banhā 2
Bari 2
Boardman 2
Bologna 2
Brno 2
Can Tho 2
Canoas 2
Cape Town 2
Changchun 2
Charlotte 2
Totale 2.244
Nome #
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 330
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 212
Prostatic hyperplasia: an unknown feature of acromegaly 184
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 165
Hepatic arterial embolization in patients with neuroendocrine tumors. 162
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 153
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 152
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 146
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 139
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 139
Prediction of efficacy of octreotide therapy in patients with acromegaly 138
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 136
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 133
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up 131
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 130
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 126
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases 124
CV 205-502 treatment in therapy-resistant acromegalic patients 121
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 121
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia 120
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 114
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 113
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 104
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 104
Effect of different dopaminergic agents in the treatment of acromegaly 104
Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results 102
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 100
Hyperprolactinemia in men: clinical and biochemical features and response to treatment 99
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly 87
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 85
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 83
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline 78
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 75
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 75
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitarytumor coincident with GNAS gene mutation. 65
Totale 4.450
Categoria #
all - tutte 14.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 1 0 0 1 5 22 2 6 38 26 40 85
2022/2023378 37 37 16 33 46 39 1 34 52 64 11 8
2023/2024133 9 32 18 7 2 8 6 13 0 1 19 18
2024/20251.013 42 29 1 10 19 52 124 72 47 105 432 80
2025/20262.006 217 99 172 180 401 83 247 114 229 153 55 56
2026/2027379 379 0 0 0 0 0 0 0 0 0 0 0
Totale 4.450